A Global Commitment: Implementing the FIP Development Goals

A Global Commitment: Implementation through the Development Goals

Pharmacists’ Contribution to Vaccination

Pharmacists have an essential public health role by acting as educators and advisers, facilitating and participating in national and global routine immunisation strategies and practices and/or delivering pharmacy-based vaccinations. Pharmacists assist in overcoming any barriers or misconceptions patients and the public have to vaccination through education, providing evidence-based information and advice to overcome misbeliefs and misconceptions regarding vaccinations. All these roles have already been successfully implemented in various countries around the world and there is a wealth of evidence of the impact of pharmacists’ vaccination-related roles, as outlined in the FIP document Expanding Immunisation Coverage Through Pharmacists.1 

The accessibility and distribution of community pharmacies usually makes them a first point of contact for patients and the public in general, providing the opportunity to promote and increase vaccination services. Due to their easy accessibility, pharmacists can more easily identify and target patients who are at higher risk of vaccine-preventable diseases and their complications. As advocates for vaccination, they build trust with the community to establish the crucial nature of vaccines and their benefits. With their knowledge of the vaccine supply chain and storage of cold products, pharmacists ensure safety and quality of vaccines.2 They are essential contributors for expanding vaccination coverage and overcoming the challenges necessary to improving vaccination compliance. 

The following video excerpt from the programme’s first episode highlights the critical role of pharmacy in the global vaccination agenda.  

FIP Commitment to Action on Improving Vaccination Coverage through Pharmacies and the pharmacy team

One of the primary outcomes of the Transforming Vaccination Regionally and Globally programme was a pledge made by pharmacists, pharmacy technicians, pharmaceutical scientists and pharmacy educators to transform vaccination globally, regionally and locally through the FIP Commitment to Action on Improving Vaccination Coverage through Pharmacies. 

The commitment, launched in December 2020 during the first FIP Virtual Global Summit on transforming vaccination in pharmacy describes 17 actions which include the following objectives:  
• To address vaccines hesitancy; 
•  To strive towards equity of access to vaccinations, with particular focus on expanding vaccination pathways for adults; 
•  To advocate legislative frameworks that provide the regulatory assurance of pharmacist-delivered vaccination services and appropriate funding models; and 
•  To ensure health system readiness for mass immunisation against current and future pandemics. 

“Pharmacy is a highly skilled and trusted health workforce that can deliver an effective and impactful health intervention. All the actions in this commitment are urgently needed to ensure equitable access to vaccines and vaccination services to all people around the world, across all ages and leaving no one behind, to reduce the burden of vaccine-preventable diseases, and to enable pharmacists to play an even greater part in the fight against emerging diseases,” said FIP CEO Dr Catherine Duggan. 

Discussions during the transforming vaccination programme provided a number of insights and priorities. The focus for FIP include : compiling country cases so that experiences can be shared; assuring quality of education and training; supporting logistics; working with other health professions to address barriers to pharmacy vaccination; providing guidelines and other support; and continuing advocacy efforts to raise awareness of the value of vaccination coverage through pharmacies. 


Watch the launch of the Commitment here


View the FIP Commitment to Action on Improving Vaccination Coverage through Pharmacies here.





Transforming Vaccination through the FIP Development Goals

The Transforming Vaccination Regionally and Globally programme was the first digital transformation series used the recently launched FIP Development Goals to unify vaccination in pharmacy across the entire profession. The second series of the programme ‘Setting transformative goals’ Discussed mechanisms and drivers to progress the most relevant FIP Development Goals (FIP DGs) in the context of transforming vaccination in pharmacy. 

The following table summarises the outcomes of series 2: key mechanisms across the FIP Development Goals that can support the transformation of vaccination in pharmacy and can serve as an action plan that could be adopted and adapted by regions and countries worldwide.  

1 – Academic Capacity

Engagement with pharmaceutical higher education development policies and ready access to leaders in all sectors of pharmacy practice and pharmaceutical science, in order to support supply-side workforce development in the areas vaccination training & service delivery.
Capacity for in-practice training and development linked with education providers; pathways for professional advancement from foundation training through to advanced practice and/or specialisation in the areas vaccination training & service delivery.
Institutional academic capacity to deliver quality pharmaceutical sciences education and training for pharmacists and pharmaceutical scientists who contribute to patient care, new discoveries and development, clinical utilisation, marketing regulations, and the economic assessment of vaccines and vaccine services.


2 – Early Career Training

Foundation training infrastructures in place for the early post-registration (post-licensing) years of the pharmaceutical workforce as a basis for consolidating initial vaccination education and training, and progressing the novice workforce qualified prior to this commitment towards qualification in vaccination service delivery.
Training strategy and infrastructures providing structured journeys for early career pharmacy practitioners and pharmacy support workers linked towards professional recognition and certification in vaccination service delivery.
Education and training of graduate/post-graduate students and early career pharmaceutical scientists to advance their skills in basic, translational, clinical, and regulatory sciences associated with vaccine development and vaccination service delivery.

3 – Quality Assurance

Transparent, contemporary and innovative processes for the quality assurance of needs-based education and training system, service delivery, and maintaining competence in vaccination delivery by pharmacists.
Training strategies and infrastructures providing early career pharmacists and pharmacy support workers professional recognition & and certification for vaccination service qualification.
Quality and integrity in research, development, manufacturing, and regulations of vaccinations and vaccination services to assure access to safe and effective medical products globally.

4 – Advanced and Specialist Development

Education and training infrastructures in place for the recognised advancement of the pharmaceutical workforce as a basis for enhancing competency of existing pharmacist workforce, in the area of vaccination delivery.
Education and training infrastructures in place for the recognized advancement of the pharmaceutical workforce in the area of vaccination service delivery as a basis for enhancing patient care and health system deliverables.
Sector-specific competency and development frameworks and infrastructures for advanced and specialised pharmacist-delivered vaccination services.

Event 2.1 is linked to Development Goal 4: Advanced and Specialist Practice.

You can watch the event recording here or download event slides.

5 – Competency Development

Clear and accessible developmental frameworks describing competencies and scope of practice for pharmacist vaccinators.
Support the development and training through short courses, certifications (recognition, credentialing) and other continuing professional development opportunities relevant to maintaining vaccination competency.
Develop evidence-based competency frameworks for pharmaceutical scientists to effectively meet the needs in academia, industry, and regulatory bodies in the development of vaccines and vaccination services.

6 – Leadership Development

Strategies and programmes in place that develop professional leadership skills (including clinical and executive leadership) relevant to the delivery and promotion of vaccinations.
Strategies and programmes for professional leadership which incorporates team- and collaborative performance, vaccine service development in line with local needs, and clinical leadership in the area of vaccination that demonstrates responsibility, accountability, decision-making ownership and professional autonomy.
Strategies and programmes for scientific leadership are in place to sustain excellence in vaccine sciences research, development, manufacturing, and regulations.

7 – Advancing Integrated Services

A patient-centred and integrated health services foundation for workforce development, relevant to social determinants of health and needs-based approaches to workforce development for the implementation of pharmacist-delivered vaccination services.
A people-centred and integrated health care provision that is based on an interprofessional and cross-setting seamless continuum including pharmacist-delivered vaccination services.
Scientific strategies to evaluate pharmacist-delivered vaccination services and programmes, including translational and reverse-translational research.

Event 2.2 is linked to Development Goal 7: Advancing Integrated Services

You can watch the event recording here or download event slides.

8 – Working with Others

Clearly identifiable elements of collaborative working and interprofessional education and training in vaccination service delivery, development of programmes, and policy development.
Clearly identifiable elements of inter- and intra-professional collaboration and multi-disciplinary healthcare, delivered through cohesive and interdependent teams working across interfaces and transitions of care to ensure maximal vaccine coverage of the public, through the utilisation of all capable workforces.
Transdisciplinary collaboration to advance education, research, development, manufacturing and regulations that collectively improve access to vaccination services.

9 – Continuing Professional Development Strategies

Existing workforce will be empowered to undertake professional development that results in the capacity of the pharmacist workforce to deliver vaccination services in all settings
In-practice and needs-based continuing professional development (CPD) and continuing education (CE) linked to career development pathways and practice frameworks, aligned with maintaining competence and recency of knowledge in the area of vaccination service delivery
Facilitate collaboration between academia, industry, and government to identify professional development priorities for pharmaceutical scientists and pharmacists in maintaining relevant knowledge in vaccine development and delivery

10 – Equity and Equality

Clear strategies for addressing equity and diversity inequalities in pharmaceutical workforce development, continued education and training, and career progression opportunities in the areas of vaccination service delivery.
Clear strategies for equity and diversity in vaccination service delivery, service access and service impact so that all people have access vaccination services, and all suitably qualified pharmacists are enabled to contribute to vaccine delivery.
Equity in global capacity of pharmaceutical sciences training, research infrastructure, development and manufacturing capabilities, and evidence-based regulatory oversight in the development and implementation of pharmacist-delivered vaccination services.

Event 2.6 is linked to Development Goal 10 Equity and Equality

You can watch the event recording here or download event slides.

11 – Impact and Outcomes

Evidence of the impact of the pharmaceutical workforce within health systems and health improvement in the delivery of vaccination services by pharmacists.
Evidence of the impact of pharmacist-delivered vaccination services in terms of health outcomes and quality of life, improved efficiency of health systems and sustainability.
Strategies and programmes in place to enable timely access to safe, effective, and affordable vaccines and methods of delivering vaccination services.

12 – Pharmacy Intelligence

An international strategy and corresponding actions to collate and share workforce data and workforce planning activities that promotes the development and implementation of pharmacist-delivered vaccination services.
A comprehensive international strategy to collate, share and utilise intelligence on service provision, development, delivery and needs to inform evidence-based services development, policymaking and funding decisions that support pharmacist-delivered vaccination services.
Data-driven decision strategies to accelerate research, development, manufacturing, and market approval of vaccines, in order to maximise clinical benefits for individual patients.

13 – Policy Development

Clear and manageable strategies to develop the pharmaceutical workforce to implement pharmacist-delivered vaccination services and address regulatory and attitudinal barriers to pharmacist-delivered vaccination services.
Clear pharmacy-led strategies to develop and implement evidence-based practice-related policies for vaccination service implementation, integration and remuneration, aligned with broader national health policies and priorities.
Defined strategies to implement needs-based pharmaceutical policies that drive national research priorities, intellectual property protection, licensing, and pricing decisions that facilitate and promote the utilisation of pharmacist-delivered vaccination services.

Event 2.6 is linked to Development Goal 13 Policy Development

You can watch the event recording here or Download event slides

14 – Medicine Expertise

Strategies and systems in place to prepare and train a workforce that can deliver expertise in vaccines and pharmacist-delivered vaccination services.
Strategies and systems in place to provide expert information and advice to patients, formal and informal caregivers, health care professionals and relevant agencies and stakeholders on vaccines and pharmacist-delivered vaccination services.
Promote use of vaccines by mobilising pharmacist expertise in the utilisation of vaccines in delivering quality health care interventions at a person and society level.

15 – People-Centred Care

Strategies in place to develop pharmaceutical education and the workforce to support the delivery of people-centred care in practice, with particular focus on debunking misinformation and disinformation about vaccination
Collaborative interprofessional strategies and people-centred professional services to support the prevention, screening, clinical management and therapeutic optimisation of vaccine-preventable diseases, and addressing fears that people have about vaccinations
Promote the provision of science-based information about vaccinations and collaborate with stakeholders to make available the latest relevant scientific information about vaccinations and vaccine-preventable diseases

16 – Communicable Diseases

Education and training infrastructures in place to develop a workforce prepared to deliver quality services around communicable and vector-borne diseases through the development of pharmacist-delivered vaccination services
Strategies and people-centred professional services for the prevention, surveillance, management and therapeutic optimisation of communicable and vector-borne diseases through the utilisation of pharmacist-delivered vaccination services
Capacity to monitor and respond to communicable disease with innovative approaches for prevention and treatment, including the development of new vaccines, vaccination methods, and the utilisation of the pharmacist workforce to rapidly deploy new vaccines into areas of emerging need.

Event 2.4 is linked to Development Goal 16 Communicable Diseases

You can watch the event recording here.

17 – Antimicrobial Stewardship

Strategies and systems in place to develop a pharmacist-delivered vaccination services as a supportive process to delivering antimicrobial stewardship through the prevention or eradiation of vaccine-preventable infections
Infrastructures and frameworks in place that support the development and utilisation of pharmacist-delivered vaccination services as a pillar of antimicrobial stewardship.
Promote research and development of new vaccination methods, new candidates for vaccines, methods for rapid identification of emerging infections, and methods for evaluating the impact of vaccination on antibiotic stewardship programmes

Event 2.5 is linked to Development Goal 17 Antimicrobial Stewardship.

You can watch the event recording here or Download event slides

18 – Access to Medicines and Services

Strategies in place to widen access to vaccinations through pharmacist-delivered vaccination services, utilising a responsive, capable, available and well-distributed pharmaceutical workforce.
Systems in place to optimise access to vaccines and pharmacist vaccination services through appropriate supply chains, quality standards, self-care & prevention services, and affordability and fair pricing policies.
Access to innovative science and information, new/innovative therapies, new delivery/manufacturing processes that enhance and complement pharmacist delivered vaccination services.

Event 2.6 is linked to Development Goal 18 Access to Medicines and Services

You can watch the event recording here or download event slides.

19 – Patient Safety

Workforce and education strategies linked to patient safety mechanism and reducing medication-related harm in practice and delivery of pharmacist-lead vaccination services
Patient safety mechanisms linked to reducing vaccination and vaccination service-related harm, quality assurance processes in vaccination service delivery, and legislation & regulations applicable to vaccination services
Safety in the development and use of vaccines and vaccine services is promoted through the advancement of vaccine safety science.

Event 2.7 is linked to Development Goal 19 Patient Safety

You can watch the event recording here or download event slides.

20 – Digital Health

Enablers of digital transformation within health infrastructure will be leveraged to assist the pharmacy workforce to implement effective processes for accessing and contributing to shared digital health records, assisting with the efficient utilisation of pharmacist-delivered vaccination services
Systems and structures in place to develop and deliver effective vaccination services through the utilisation of quality digital health services, digital literacy, utilisation of technology, utilisation of digital enablers, and configuration of responsive digital services to widen access and equity to pharmacist delivered vaccination services.
Application of and access to digital technology in healthcare delivery and development, that delivers a collaborative model of health care utilising the expertise of all health professionals in the effective delivery of vaccination services

21 – Sustainability in Pharmacy

Strategies and systems in place that utilise the workforce to enhance sustainable pharmacist-delivered vaccination services.
Policies, regulations and strategies to ensure the sustainability of the environment and minimise the impact of vaccination services. Appropriate mechanisms to ensure the sustainability of pharmacist-delivered vaccination services, through appropriate remuneration models.
Scientific strategies and policies in place to maintain consistent supply of vaccinations throughout lifecycle while limiting negative consequences for the environment